Closing-Day Recap of BIO 2015: What the Official Bloggers Have to Say

Closing-Day Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday during the BIO International Convention our BIO Official Bloggers, writers who are on top of the biotechnology beat, release statements about their experience at the BIO International Convention. Here is what they have to say about the closing day:

Genomics Blog
By Mike Spear

You probably snore when you’re asleep.  45% of the population in the UK and the EU snore and 64% of American households have someone who snores. It is generally irritating to other people close to an individual who snores but it can be much more than that. It can cause serious sleep disturbances in the snorer or in other members of a household, and can lead to ongoing fatigue. You can try changing your sleep position, change your pillow, stay hydrated, and avoid alcohol before bed, but changing sleep habits is often not enough. Read more…

The Rhone-Alpes region in France is home to a major biotech cluster and has also been twinned with the city of Philadelphia for a number of years, so it is somewhat fitting that Philadelphia is hosting BIO on the 10th anniversary of Lyonbiopole. Read more…

Research! America

A global solution and removing barriers to antibiotic development are necessary to combat antimicrobial resistance (AMR). Representatives from various research and health sectors discussed strategies for fighting superbugs at a BIO International Convention super session today. The panel agreed there must be a greater focus on streamlining clinical trials and harmonizing the global regulatory process to support the development of new antibiotics. Read more…

Astronaut Scott Kelly described the type of work underway on the International Space Station in a special satellite uplink at today’s BIO International Convention luncheon. During a live interview, floating in zero-gravity, Kelly said they’re working on 400 scientific projects on the station, and they hope to learn more about such things as bone loss and muscle wasting disease in space. With the latest technology, he said they’re able to get plenty of data on human health performance and physiology, adding he hopes to learn “if there is a cliff out there in regards to our physiology as we go from six months to a year and longer.” Read more…

Bloomberg BNA- Health Care Blog
By John T. Aquino

Patent eligibility has been an issue for the life sciences industry since two Supreme Court decisions that panelists Wednesday at a BIO session said have driven the patent system into “chaos.” Read more…

The last day at the BIO convention. It’s been my ninth. Compared to some I’m a veteran and to others, maybe many others, I’m an infant. Read more…

My Bloomberg BNA colleague, correspondent Leslie Pappas, covered National Institutes of Health Director Francis Collins’ remarks Wednesday. He said that the NIH has carried out an extensive survey over several months to find out how the public feels about sharing their personal health data and whether they would participate in a long-term, national research project on personalized medicine. Read more…

My Bloomberg BNA colleague, correspondent Leslie Pappas, covered National Institutes of Health Director Francis Collins’ remarks Wednesday. He said that the NIH has carried out an extensive survey over several months to find out how the public feels about sharing their personal health data and whether they would participate in a long-term, national research project on personalized medicine. Read more…

Pink Sheet
By Lisa LaMotta

Business development executives from AstraZeneca, Novartis and Almirall discussed the benefits of assets swaps and if they think mega-mergers are an outdated trend. Read more…

By Sue Sutter

Chinese regulatory requirements are making it difficult for biosimilar companies to incorporate China into global development programs, a Pfizer Inc. representative told the Biotechnology Industry Organization’s annual meeting June 17. Read more…

Patent Docs
By Kevin Noonan

As part of his remarks during the Keynote Luncheon earlier today at the Biotechnology Industry Organization (BIO) International Meeting, New BIO Chairman of the Board Ron Cohen announced that BIO will be changing its name to the Biotechnology Innovation Organization.  The change “better expresses the essence of what our member companies represent,” according to Mr. Cohen, who is also CEO of Acorda Therapeutics.  Jim Greenwood, longtime BIO President and CEO, called it “a great move that will help clarify for policymakers and the public the heart of our industry — scientific innovation that will help to heal, feed and fuel the world.” Read more…

Informa 2015 BIO Blog
By Lisa LaMotta

Top 10 Topics Buzzing at #BIO2015. See the list…

By Sue Sutter

In early February, biosimilar developer Pfenex Inc. was on the verge of a transformative deal with Hospira Inc. to bring a proposed biosimilar of Genentech Inc.’s ocular VEGF-inhibitor Lucentis (ranibizumab) to market.Then it got some news that caused a bit of gastroesophageal reflux: Pfizer Inc. was acquiring Hospira for $17 billion. Read more…

BioTech Blog
By Yali Friedman

On Thursday June 18th from 12:30 to 2pm in Room 119B Mike May and I will be going over the seventh edition of Scientific American Worldview. Mike is the editor of Worldview. This is a more intimate session than the Super Session (below), and we will discuss the impetus for developing Worldview as well highlighting our findings from this year, and the trends we have seen over time. This is your best opportunity to have a deep discussion with the developers of Worldview. Read more…

I will be signing my textbook Building Biotechnology, and other books, in the BIO bookstore on Thursday June 18th from 10:00 am – 11:30 am. Building Biotechnology is used by dozens of schools, and I am always happy to meet professors, students, and industry professionals who have used the book. Stop by, even if it is just to say hello 🙂 Read more…

Nature.com
By Brady Huggett

Before BIO CEO Jim Greenwood interviewed broadcast journalist Tom Brokaw during Tuesday’s plenary lunch, Philadelphia Mayor Michael Nutter took the podium. This is standard fare for a BIO convention: the hosting mayor gets a chance to brag a little bit about their city, and thank BIO for bringing all these people to local hotels and restaurants. Read more…

Filed under: Events, , , ,